WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012054716) PIPERIDIN-4-YL-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/054716    International Application No.:    PCT/US2011/057085
Publication Date: 26.04.2012 International Filing Date: 20.10.2011
IPC:
A61P 29/00 (2006.01), A61K 31/4523 (2006.01), C07D 205/04 (2006.01), C07D 211/16 (2006.01), C07D 417/12 (2006.01), C07D 417/14 (2006.01)
Applicants: JANSSEN PHARMACEUTICA NV. [BE/BE]; Turnhoutseweg 30 B-2340 Beerse (BE) (For All Designated States Except US).
CONNOLLY, Peter, J. [US/US]; (US) (For US Only).
BIAN, Haiyan [US/US]; (US) (For US Only).
LI, Xun [US/US]; (US) (For US Only).
LIU, Li [US/US]; (US) (For US Only).
MACIELAG, Mark, J. [US/US]; (US) (For US Only).
MCDONNELL, Mark, E. [US/US]; (US) (For US Only)
Inventors: CONNOLLY, Peter, J.; (US).
BIAN, Haiyan; (US).
LI, Xun; (US).
LIU, Li; (US).
MACIELAG, Mark, J.; (US).
MCDONNELL, Mark, E.; (US)
Agent: JOHNSON, Philip, S.; Johnson & Johnson One Johnson & Johsnon Plaza New Brunswick, NJ 08933 (US)
Priority Data:
61/405,876 22.10.2010 US
Title (EN) PIPERIDIN-4-YL-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS
(FR) PIPÉRIDIN-4-YL-AZÉTIDINE DIAMIDES EN TANT QU'INHIBITEURS DE LA MONOACYLGLYCÉROL LIPASE
Abstract: front page image
(EN)Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (I) as follows: Formula (I), wherein Y, Z, and R are defined herein.
(FR)L'invention concerne des composés, des compositions et des méthodes de traitement de diverses maladies, divers syndromes, états et troubles, notamment la douleur. De tels composés et des énantiomères, diastéréoisomères et sels pharmaceutiquement acceptables de ceux-ci, sont représentés par la Formule (I) suivante : Formule (I), où Y, Z et R sont définis dans la description.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)